News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chelsea Therapeutics, Inc. (CHTP) Completes Public Offering Of Common Stock



11/18/2013 9:13:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHARLOTTE, N.C., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP), a development stage pharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products, announced today that it has completed its previously announced public offering of 7,666,667 shares of its common stock, including 1,000,000 shares of common stock that were issued upon exercise in full of the over-allotment option granted to the underwriters. Exercise of the full over-allotment option increases the net proceeds to the Company, after underwriting discounts and commissions and expenses, from approximately $18.6 million to approximately $21.4 million.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES